Donatella D'Urso

Title: Donatella D'Urso: Innovator in Biomarker Research

Introduction

Donatella D'Urso is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of biomarker research, particularly in relation to various diseases. Her work focuses on the identification and application of biomarkers that can aid in the diagnosis and treatment of serious health conditions.

Latest Patents

Donatella D'Urso holds a patent for her invention titled "LTBP2 as a biomarker and diagnostic target." This invention provides LTBP2, which is associated with cardiovascular diseases, hematological diseases, neurological diseases, cancer, endocrinological diseases, and urological diseases. The invention also includes assays for identifying compounds useful in the treatment or prevention of these diseases. Additionally, it features compounds that bind to and/or activate or inhibit the activity of LTBP2, as well as pharmaceutical compositions comprising such compounds. LTBP2 is presented as a valuable biomarker for various diseases, enhancing the potential for targeted therapies.

Career Highlights

Throughout her career, Donatella D'Urso has worked with notable companies, including Bayer Schering Pharma AG and Bayer Intellectual Property GmbH. Her experience in these organizations has allowed her to develop her expertise in biomarker research and innovation.

Collaborations

Donatella has collaborated with esteemed colleagues such as Stefan Golz and Holger Summer. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Donatella D'Urso is a trailblazer in the field of biomarker research, with her innovative work paving the way for advancements in the diagnosis and treatment of various diseases. Her contributions are invaluable to the medical community and continue to inspire future research.